• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保乳术联合术中放疗治疗乳腺原位癌:单中心经验。

Oncoplastic breast-conserving therapy and intraoperative radiotherapy for management of carcinoma in situ of the breast: A single-center experience.

机构信息

Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Breast Surgery, True Family Women's Cancer Center, Seattle, WA, USA.

出版信息

Breast J. 2020 Dec;26(12):2391-2394. doi: 10.1111/tbj.14093. Epub 2020 Dec 6.

DOI:10.1111/tbj.14093
PMID:33283376
Abstract

Intraoperative radiation therapy (IORT) has been shown to reduce local recurrence rates among women with early-stage invasive ductal carcinoma, but data regarding its use among women with in situ carcinoma are limited. In this single-institution study, 50 women with in situ carcinoma were treated with oncoplastic breast-conserving surgery (OPS) and single-dose IORT. All 50 patients had "no tumor on ink," but 9 (16%) had margins < 2 mm and required additional therapy. No local recurrences were observed after a median follow-up of 46 months. Single-dose IORT is an efficacious treatment for well-selected patients with DCIS.

摘要

术中放疗(IORT)已被证明可降低早期浸润性导管癌女性的局部复发率,但有关其在原位癌女性中应用的数据有限。在这项单机构研究中,50 例原位癌患者接受了保乳整形手术(OPS)和单次剂量 IORT 治疗。所有 50 例患者均为“墨水上无肿瘤”,但有 9 例(16%)切缘<2mm,需要额外治疗。中位随访 46 个月后,未观察到局部复发。单次剂量 IORT 是一种有效的治疗方法,适用于选择良好的 DCIS 患者。

相似文献

1
Oncoplastic breast-conserving therapy and intraoperative radiotherapy for management of carcinoma in situ of the breast: A single-center experience.保乳术联合术中放疗治疗乳腺原位癌:单中心经验。
Breast J. 2020 Dec;26(12):2391-2394. doi: 10.1111/tbj.14093. Epub 2020 Dec 6.
2
Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.靶向术中放疗用于治疗乳腺导管原位癌
Breast J. 2016 Jan-Feb;22(1):63-74. doi: 10.1111/tbj.12516. Epub 2015 Nov 3.
3
Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy.术中放疗(IORT)是既往接受过外照射放疗后出现局部乳腺复发患者的一种选择。
BMC Cancer. 2007 Sep 14;7:178. doi: 10.1186/1471-2407-7-178.
4
Survival benefit of breast-conserving surgery with adjuvant radiotherapy for young women with ductal carcinoma in situ: A population-based cohort study.保乳手术联合辅助放疗对年轻导管原位癌女性的生存益处:一项基于人群的队列研究。
Asian J Surg. 2023 Aug;46(8):3173-3175. doi: 10.1016/j.asjsur.2023.02.107. Epub 2023 Mar 8.
5
Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.保乳手术及乳腺导管原位癌(导管内癌)根治性放疗后局部复发的挽救性治疗。
Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):3-9. doi: 10.1016/0360-3016(94)90512-6.
6
Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving Treatment.重新定义资格:分析因术中放射治疗取消而作为保乳治疗患者辅助治疗的情况。
Ann Surg Oncol. 2019 Dec;26(13):4294-4301. doi: 10.1245/s10434-019-07819-5. Epub 2019 Sep 13.
7
Adjuvant Radiation Therapy for Ductal Carcinoma In Situ of the Breast: A Clinician's Dilemma.乳腺癌导管原位癌的辅助放疗:临床医生的困境
Ann Surg Oncol. 2023 Oct;30(11):6281-6283. doi: 10.1245/s10434-023-13691-1. Epub 2023 Jun 6.
8
Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast.与乳腺导管内癌(原位导管癌)治疗相关的病理生物学考量
CA Cancer J Clin. 1997 Jan-Feb;47(1):52-64. doi: 10.3322/canjclin.47.1.52.
9
Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.接受术中电子束增强放疗与术后外照射电子束增强放疗的乳腺癌患者的局部复发率。一项序贯干预研究。
Strahlenther Onkol. 2004 Jan;180(1):38-44. doi: 10.1007/s00066-004-1190-9.
10
Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.保乳手术后原位导管癌与浸润性乳腺癌同侧乳腺肿瘤复发情况的比较。
World J Surg Oncol. 2016 Apr 27;14:126. doi: 10.1186/s12957-016-0885-6.

引用本文的文献

1
Oncoplastic Breast Surgery versus Conservative Mastectomy in the Management of Large Ductal Carcinoma In Situ (DCIS): Surgical, Oncological, and Patient-Reported Outcomes.保乳整形手术与保乳根治术治疗乳腺导管原位癌(DCIS)的疗效比较:手术、肿瘤学及患者报告结局
Cancers (Basel). 2022 Nov 16;14(22):5624. doi: 10.3390/cancers14225624.
2
The Selection of Treatment Modality for Breast Ductal Carcinoma In Situ: Experience From a Single Institution.乳腺导管原位癌治疗方式的选择:单中心经验。
Cancer Control. 2021 Jan-Dec;28:1073274821997426. doi: 10.1177/1073274821997426.